Global Longlife Hospital and Research Limited (GLHRL.BO)
BSE · INR · Healthcare · Medical Care Facilities
₹11.76 (-4.93%) as of
Key statistics
- Market cap
- 123.48M
- EPS (TTM)
- -1.64
- Dividend yield
- 0.00%
- 52-week range
- 9.00 – 25.80
- Beta
- -0.20
- Revenue (TTM)
- 52k
- Profit margin
- 0.00%
- Volume
- 25.00k
About Global Longlife Hospital and Research Limited
Global Longlife Hospital and Research Limited, a multi-speciality tertiary care hospital, provides medical and surgical specialities services in India. It offers medical services, such as oncology, ophthalmology, allergy and immunology, pain management, pulmonology, anaesthesiology, cardiology, dermatology, critical care, diabetes and endocrinology, GI medicine, gynecology, infectious disease, nephrology, and neurology; and surgical services, including CVTS, joint replacement orthopaedics, spine surgery, general surgery, onco surgery, GI surgery, neurosurgery, ENT, plastic surgery, trauma centre, urology, laparoscopic surgery, gynaecology, dental surgery, and vascular surgery. It also provides radiology services comprising mammography, CT scan, X-ray, ultrasound, endoscopy, and sonography; pathology services, such as microbiology, biochemistry, clinical pathology, cyto pathology, haematology, and serology; and other services that include dialysis, pharmacy, ambulance, dietary, and physiotherapy services. Global Longlife Hospital and Research Limited was incorporated in 2012 and is based in Ahmedabad, India.
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Headquarters
- Ahmedabad, India
- Employees
- 3
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.